CAR/CXCR5-T cell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection.

Autor: Pampusch MS; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Abdelaal HM; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Cartwright EK; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Molden JS; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Davey BC; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Sauve JD; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Sevcik EN; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Rendahl AK; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America., Rakasz EG; Wisconsin National Primate Research Center, University of Wisconsin, Madison, Wisconsin, United States of America., Connick E; Division of Infectious Diseases, University of Arizona, Tucson, Arizona, United States of America., Berger EA; Laboratory of Viral Diseases, NIAID, NIH, Bethesda, Maryland, United States of America., Skinner PJ; Department of Veterinary and Biomedical Sciences, University of Minnesota, St. Paul, Minnesota, United States of America.

Publikováno v: PLoS pathogens [PLoS Pathog] 2022 Feb 07; Vol. 18 (2), pp. e1009831. Date of Electronic Publication: 2022 Feb 07 (Print Publication: 2022).